Overview of the Global Market for Medicaments Containing Insulin But Not Antibiotics In Measured Doses

Market Size for Medicaments Containing Insulin But Not Antibiotics In Measured Doses

The global prophylactic medicaments containing insulin market rose to $X in 2022, picking up by 2.6% against the previous year. Over the period under review, the total consumption indicated a resilient expansion from 2012 to 2022: its value increased at an average annual rate of +6.6% over the last decade. The trend pattern, however, indicated some noticeable fluctuations being recorded throughout the analyzed period. Based on 2022 figures, consumption decreased by -2.7% against 2020 indices. Global consumption peaked at $X in 2020; however, from 2021 to 2022, consumption failed to regain momentum.

Production of Medicaments Containing Insulin But Not Antibiotics In Measured Doses

In value terms, prophylactic medicaments containing insulin production expanded to $X in 2022 estimated in export price. In general, the total production indicated buoyant growth from 2012 to 2022: its value increased at an average annual rate of +6.6% over the last decade. The trend pattern, however, indicated some noticeable fluctuations being recorded throughout the analyzed period. Based on 2022 figures, production decreased by -3.3% against 2020 indices. The growth pace was the most rapid in 2013 with an increase of 31% against the previous year. Over the period under review, global production reached the peak level at $X in 2020; however, from 2021 to 2022, production failed to regain momentum.

Exports of Medicaments Containing Insulin But Not Antibiotics In Measured Doses

Exports

In 2022, shipments abroad of medicaments containing insulin but not antibiotics in measured doses increased by 15% to X tons, rising for the second consecutive year after two years of decline. The total export volume increased at an average annual rate of +4.0% over the period from 2012 to 2022; the trend pattern remained consistent, with only minor fluctuations in certain years. The most prominent rate of growth was recorded in 2013 when exports increased by 37% against the previous year. Over the period under review, the global exports reached the maximum in 2022 and are expected to retain growth in the near future.

In value terms, prophylactic medicaments containing insulin exports shrank to $X in 2022. Overall, exports recorded a relatively flat trend pattern. The pace of growth appeared the most rapid in 2013 with an increase of 28% against the previous year. The global exports peaked at $X in 2014; however, from 2015 to 2022, the exports stood at a somewhat lower figure.

Exports by Country

France was the main exporter of medicaments containing insulin but not antibiotics in measured doses in the world, with the volume of exports amounting to X tons, which was near 41% of total exports in 2022. The United States (X tons) took the second position in the ranking, followed by Italy (X tons), Germany (X tons), India (X tons), China (X tons) and Brazil (X tons). All these countries together took near 44% share of total exports. Turkey (X tons) took a little share of total exports.

From 2012 to 2022, average annual rates of growth with regard to prophylactic medicaments containing insulin exports from France stood at +7.2%. At the same time, Turkey (+73.7%), China (+44.4%), Italy (+10.1%) and the United States (+4.3%) displayed positive paces of growth. Moreover, Turkey emerged as the fastest-growing exporter exported in the world, with a CAGR of +73.7% from 2012-2022. Germany experienced a relatively flat trend pattern. By contrast, India (-6.4%) and Brazil (-8.4%) illustrated a downward trend over the same period. While the share of France (+11 p.p.), China (+5 p.p.), Italy (+3.7 p.p.) and Turkey (+2.3 p.p.) increased significantly in terms of the global exports from 2012-2022, the share of Germany (-2.6 p.p.), Brazil (-12 p.p.) and India (-13.2 p.p.) displayed negative dynamics. The shares of the other countries remained relatively stable throughout the analyzed period.

In value terms, the largest prophylactic medicaments containing insulin supplying countries worldwide were Germany ($X), France ($X) and China ($X), with a combined 72% share of global exports. Italy, the United States, India, Brazil and Turkey lagged somewhat behind, together comprising a further 20%.

Turkey, with a CAGR of +52.4%, saw the highest growth rate of the value of exports, in terms of the main exporting countries over the period under review, while shipments for the other global leaders experienced more modest paces of growth.

Export Prices by Country

In 2022, the average prophylactic medicaments containing insulin export price amounted to $X per ton, waning by -19.8% against the previous year. In general, the export price showed a pronounced slump. The pace of growth was the most pronounced in 2014 an increase of 7.8% against the previous year. As a result, the export price reached the peak level of $X per ton. From 2015 to 2022, the average export prices remained at a somewhat lower figure.

Prices varied noticeably by country of origin: amid the top suppliers, the country with the highest price was Germany ($X per ton), while Brazil ($X per ton) was amongst the lowest.

From 2012 to 2022, the most notable rate of growth in terms of prices was attained by India (+5.2%), while the other global leaders experienced more modest paces of growth.

Imports of Medicaments Containing Insulin But Not Antibiotics In Measured Doses

Imports

In 2022, overseas purchases of medicaments containing insulin but not antibiotics in measured doses decreased by -7.6% to X tons, falling for the second consecutive year after three years of growth. The total import volume increased at an average annual rate of +2.8% from 2012 to 2022; the trend pattern remained consistent, with somewhat noticeable fluctuations being recorded in certain years. The pace of growth was the most pronounced in 2016 when imports increased by 11% against the previous year. Over the period under review, global imports reached the maximum at X tons in 2020; however, from 2021 to 2022, imports remained at a lower figure.

In value terms, prophylactic medicaments containing insulin imports reduced markedly to $X in 2022. Overall, imports continue to indicate a mild decline. The most prominent rate of growth was recorded in 2014 with an increase of 14% against the previous year. As a result, imports reached the peak of $X. From 2015 to 2022, the growth of global imports remained at a lower figure.

Imports by Country

In 2022, the United States (X tons), followed by France (X tons), Germany (X tons), Turkey (X tons) and Canada (X tons) represented the largest importers of medicaments containing insulin but not antibiotics in measured doses, together constituting 38% of total imports. Japan (X tons), Algeria (X tons), Hungary (X tons), Spain (X tons), Italy (X tons), Colombia (X tons), China (X tons) and Pakistan (X tons) took a minor share of total imports.

From 2012 to 2022, the most notable rate of growth in terms of purchases, amongst the leading importing countries, was attained by Colombia (with a CAGR of +20.6%), while imports for the other global leaders experienced more modest paces of growth.

In value terms, the largest prophylactic medicaments containing insulin importing markets worldwide were the United States ($X), France ($X) and Germany ($X), together accounting for 35% of global imports. Canada, Japan, China, Algeria, Hungary, Turkey, Italy, Spain, Pakistan and Colombia lagged somewhat behind, together accounting for a further 25%.

Among the main importing countries, Pakistan, with a CAGR of +17.0%, recorded the highest growth rate of the value of imports, over the period under review, while purchases for the other global leaders experienced more modest paces of growth.

Import Prices by Country

The average prophylactic medicaments containing insulin import price stood at $X per ton in 2022, with a decrease of -14.6% against the previous year. In general, the import price saw a noticeable decline. The most prominent rate of growth was recorded in 2020 when the average import price increased by 6.2%. Over the period under review, average import prices reached the maximum at $X per ton in 2014; however, from 2015 to 2022, import prices failed to regain momentum.

There were significant differences in the average prices amongst the major importing countries. In 2022, amid the top importers, the country with the highest price was China ($X per ton), while Colombia ($X per ton) was amongst the lowest.

From 2012 to 2022, the most notable rate of growth in terms of prices was attained by Pakistan (+14.6%), while the other global leaders experienced more modest paces of growth.

Source: IndexBox Platform

Frequently Asked Questions (FAQ) :